🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To determine the toxicities, maximum tolerated dose (MTD) and recommended p...
Status
Completed
Location
Indiana University Cancer Center
Start Date
2006-10
Trial ID
NCT00408226
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2000-10
Trial ID
NCT00014365
Treatments Being Tested
This is an open-label study to determine the highest dose of MKC-1 that may...
Status
Completed
Location
U. of Wisconsin Paul P. Carbone Comprehensive Cancer Center
Start Date
2008-03
Trial ID
NCT00656461
Treatments Being Tested
This phase 2 study will determine the antitumor activity, based on the obje...
Status
Completed
Location
IUPUI
Start Date
2006-01
Trial ID
NCT00306631
Treatments Being Tested
To determine the antitumor activity of MKC-1 in patients with unresectable ...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2007-11
Trial ID
NCT00568646
Treatments Being Tested
The main objectives of this study are to evaluate the side effects of MKC-1...
Status
Completed
Location
Princess Margaret Hospital
Start Date
2006-11
Trial ID
NCT00506402
Treatments Being Tested
Patients will be treated with MKC-1, twice daily for 14 consecutive days ev...
Status
Completed
Location
Juravinski Cancer Centre
Start Date
2008-01
Trial ID
NCT00607607
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
1998-10
Trial ID
NCT00003755
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2000-12
Trial ID
NCT00016250
Treatments Being Tested